Millions of US adults aged 70 years and over previously advised to take aspirin for primary prevention would not now have it recommended for routine continued use — in particular those with diabetes ...

While research shows that taking a daily dose of aspirin could have some definite pros and cons, a new study adds a tick to the pro column. It was found that low-dose supplementation with the drug ...

DOCTOR OR A NEW STUDY SHOWS TAKING A LOW DOSE ASPIRIN COULD HELP REDUCE THE RISK OF DIABETES IN OLDER ADULTS. MERCY MEDICAL CENTER NURSE PRACTITIONER JENNIFER PIPER JOINS US NOW WITH MORE INFORMATION.

MORE THAN 500 RNS WHO ARE AT SAINT AGNES. A NEW STUDY LOOKS AT WHETHER TAKING A LOW DOSE ASPIRIN REDUCES THE RISK OF DIABETES AND OLDER ADULTS. EXPERTS SAY THE RESEARCH DOES SHOW THE ASPIRIN CAN HAVE ...

Aspirin (search) and related drugs may have something to teach us about how insulin (search) resistance develops. Insulin resistance can lead to obesity and type 2 diabetes (search). How this occurs ...

New research to be presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 October) shows that use of low dose (100mg daily) ...

Previous guidelines recommended low-dose aspirin therapy for the primary prevention of stroke in patients with type 1 or type 2 diabetes mellitus who were at increased cardiovascular (CV) risk. Risk ...

New research presented at the 5th Heart in Diabetes Conference highlights potential therapeutic options for patients with COVID-19 and diabetes. In one abstract 1 presented at the conference, ...

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...

New research suggests that taking a daily aspirin may halve your risk of developing diabetes, especially during the COVID-19 pandemic, by targeting inflammation, but not without trade-offs. Study: ...

Adults with Type 2 diabetes (T2D) and at moderate or high risk of cardiovascular disease who took low-dose aspirin were less likely to experience a serious cardiovascular event, including a heart ...